Can health care databases be used to identify incident cases of osteonecrosis?

Por Vlad, Steven C, Felson, David T, Miller, Donald R
Publicado em 2009

Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) i...

Por Best, Jennie H., Vlad, Steven C., Pei, Jinglan
Publicado no Rheumatol Ther (2020)

Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Anothe...

Por Best, Jennie H., Vlad, Steven C., Tominna, Lenore, Abbass, Ibrahim
Publicado no Rheumatol Ther (2020)

Protective effects of NSAIDs on the development of Alzheimer disease

Por Vlad, Steven C., Miller, Donald R., Kowall, Neil W., Felson, David T.
Publicado em 2008

No Association Between Markers of Inflammation and Osteoarthritis of the Hands and Knees

Por VLAD, STEVEN C., NEOGI, TUHINA, ALIABADI, PIRAN, FONTES, JOÃO D.T., FELSON, DAVID T.
Publicado em 2011

Defining Remission in Rheumatoid Arthritis: Results of an Initial ACR Consensus Conference

Por van Tuyl, Lilian H. D., Vlad, Steven C., Felson, David T., Wells, George, Boers, Maarten
Publicado em 2009